
Profound Medical Corp. PROF
€ 4.49
-3.52%
Geschäftsbericht 2023
hinzugefügt 27.12.2025
Profound Medical Corp. Betriebsaufwand 2011-2026 | PROF
Betriebsaufwand Jährlich Profound Medical Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33 M | 35.1 M | 33.2 M | 22.3 M | 17.3 M | 21 M | 19.5 M | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 35.1 M | 17.3 M | 25.9 M |
Betriebsaufwand anderer Aktien in der Medizinische Geräte
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
614 M | $ 11.68 | -3.87 % | $ 1.75 B | ||
|
Butterfly Network
BFLY
|
123 M | $ 4.21 | 0.48 % | $ 891 M | ||
|
Bruker Corporation
BRKR
|
1.4 B | $ 35.45 | 1.69 % | $ 5.28 K | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 9.38 | -1.37 % | $ 266 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
FONAR Corporation
FONR
|
28.7 M | $ 18.34 | - | $ 120 M | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
Inogen
INGN
|
184 M | $ 6.28 | -2.64 % | $ 167 M | ||
|
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.36 | 0.37 % | $ 21.9 M | ||
|
Integer Holdings Corporation
ITGR
|
279 M | $ 84.19 | -1.34 % | $ 2.92 B | ||
|
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | ||
|
LENSAR
LNSR
|
32.6 M | $ 5.9 | -2.8 % | $ 68 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
Medtronic PLC
MDT
|
15.3 B | $ 86.9 | -0.31 % | $ 112 B | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
LivaNova PLC
LIVN
|
697 M | $ 62.72 | -0.82 % | $ 3.42 B | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Myomo
MYO
|
41.3 M | $ 0.7 | -1.45 % | $ 29.3 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
60 M | $ 2.36 | -3.48 % | $ 138 M | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 8.96 | -1.54 % | $ 321 M | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Orthofix Medical
OFIX
|
344 M | $ 11.86 | -0.08 % | $ 470 M | ||
|
Outset Medical
OM
|
113 M | $ 3.47 | -3.97 % | $ 52.8 K | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
Penumbra
PEN
|
753 M | $ 334.37 | -0.35 % | $ 13 B | ||
|
AxoGen
AXGN
|
121 M | $ 31.83 | 0.25 % | $ 1.47 B | ||
|
CONMED Corporation
CNMD
|
648 M | $ 36.36 | -0.74 % | $ 1.13 B | ||
|
Insulet Corporation
PODD
|
531 M | $ 223.84 | -1.43 % | $ 15.7 B | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Electromed
ELMD
|
40.3 M | $ 24.12 | -1.51 % | $ 204 M | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Quanterix Corporation
QTRX
|
191 M | $ 3.74 | -5.18 % | $ 159 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.66 | -2.02 % | $ 35.9 M | ||
|
Aethlon Medical
AEMD
|
9.34 M | $ 2.24 | -2.61 % | $ 3.5 M | ||
|
Sintx Technologies
SINT
|
11.2 M | $ 2.55 | - | $ 7.07 M | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
59.6 M | $ 10.74 | 3.52 % | $ 1.45 B | ||
|
Tactile Systems Technology
TCMD
|
221 M | $ 26.2 | -1.17 % | $ 599 M | ||
|
IRadimed Corporation
IRMD
|
38.2 M | $ 99.67 | 0.47 % | $ 1.27 B |